Population
Intact arterial smooth muscle
Comparison
KN-93 (CaM kinase II inhibitor) pretreatment vs No KN-93 pretreatment
Design
Preclinical
Authors
Loading...
KN-93 attenuates CaMKII-dependent force in animal arteries; hypothesis-generating for CaMKII in human vascular tone.
KN-93 inhibits CaM kinase II activation and force maintenance in arterial smooth muscle, highlighting the role of CaM kinase II in regulating tonic contractile responses.
Rokolya et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: